Recombinant modified-C reactive protein (NextEra Therapeutics/Immtech Pharmaceuticals)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant modified-C reactive protein (NextEra Therapeutics/Immtech Pharmaceuticals)
Drug Alias Namer(m)CRP
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNextera TherapeuticsImmtech Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNextera TherapeuticsImmtech Pharmaceutical
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A